REPL250919C00002500 Option on Replimune Group
REPL Stock | USD 7.60 0.57 8.11% |
REPL250919C00002500 is a PUT option contract on Replimune's common stock with a strick price of 2.5 expiring on 2025-09-19. The contract was not traded in recent days and, as of today, has 47 days remaining before the expiration. The option is currently trading at a bid price of $4.7, and an ask price of $5.2. The implied volatility as of the 3rd of August is 47.0.
Replimune | Build AI portfolio with Replimune Stock |
When exercised, put options on Replimune produce a short position in Replimune Stock. Because of this protective nature, they are typically used either for hedging purposes or to capitalize on Replimune's downside price movement.
Rule 16 of 2025-09-19 Option Contract
The options market is anticipating that Replimune Group will have an average daily up or down price movement of about 0.13% per day over the life of the option. With Replimune trading at USD 7.6, that is roughly USD 0.009642. If you think that the market is fully understating Replimune's daily price movement you should consider buying Replimune Group options at that current volatility level of 2.03%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
In The Money Call Option on Replimune
An 'In The Money' option is one with a strike price that the current stock price has already surpassed. Some options investors can hedge their Replimune positions using in-the-money options. They may also want to buy options with some intrinsic value, not just time value. However, because in-the-money options on Replimune Stock have intrinsic value and are priced higher than out-of-the-money options in the same chain, their volatilities are relatively smaller.
Call Contract Name | REPL250919C00002500 |
Expires On | 2025-09-19 |
Days Before Expriration | 47 |
Delta | 0.970376 |
Vega | 0.001856 |
Gamma | 0.012033 |
Theoretical Value | 5.2 |
Open Interest | 311 |
Current Trading Volume | 13.0 |
Strike Price | 2.5 |
Last Traded At | 5.1 |
Current Price Spread | 4.7 | 5.2 |
Rule 16 Daily Up or Down | USD 0.009642 |
Replimune short PUT Option Greeks
Replimune's Option Greeks for the contract ending on 2025-09-19 at a strike price of 2.5 measures the various factors that affect its cost and calculated using a theoretical options pricing model. It helps investors make more informed decisions about whether to trade this option contract or when to trade it. In addition to Replimune's option greeks, its implied volatility helps estimate the risk of Replimune stock implied by the prices of the options on Replimune's stock.
Delta | 0.970376 | |
Gamma | 0.012033 | |
Theta | -0.004185 | |
Vega | 0.001856 | |
Rho | 0.00286 |
Replimune long PUT Option Payoff at expiration
Put options written on Replimune grant holders of the option the right to sell a specified amount of Replimune at a specified price within a specified time frame. The put buyer has a limited loss and, while not fully unlimited gains, as the price of Replimune Stock cannot fall below zero, the put buyer does gain as the price drops. So, purchasing a put option on Replimune is like buying insurance aginst Replimune's downside shift.
Profit |
Replimune Price At Expiration |
Replimune short PUT Option Payoff at expiration
By selling Replimune's put option, the investors signal their bearish sentiment. A short position in a put option written on Replimune will generally make money when the underlying price is above the strike price. Therefore Replimune's put payoff at expiration depends on where the Replimune Stock price is relative to the put option strike price. The breakeven price of 7.7 is the critical point that divides the payoff function into two parts. Below the breakeven price, the payoff is dropping and negative (the seller makes a loss). Above the breakeven price, the payoff line is upward sloping as the option payoff increases in proportion to Replimune's price. Finally, at the strike price of 2.5, the payoff chart is constant and positive.
Profit |
Replimune Price At Expiration |
Replimune Group Available Call Options
Replimune's option chain is a display of a range of information that helps investors for ways to trade options on Replimune. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Replimune. It also shows strike prices and maturity days for a Replimune against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone.
Open Int | Strike Price | Current Spread | Last Price | |||
Call | REPL250919C00022500 | 37 | 22.5 | 0.0 - 0.5 | 0.1 | Out |
Call | REPL250919C00020000 | 58 | 20.0 | 0.0 - 0.4 | 0.2 | Out |
Call | REPL250919C00017500 | 48 | 17.5 | 0.0 - 0.45 | 0.2 | Out |
Call | REPL250919C00015000 | 102 | 15.0 | 0.0 - 0.45 | 0.17 | Out |
Call | REPL250919C00012500 | 638 | 12.5 | 0.25 - 0.45 | 0.3 | Out |
Call | REPL250919C00010000 | 1797 | 10.0 | 0.5 - 0.95 | 0.55 | Out |
Call | REPL250919C00007500 | 779 | 7.5 | 1.15 - 1.45 | 1.3 | In |
Call | REPL250919C00005500 | 35 | 5.5 | 2.3 - 2.95 | 2.31 | In |
Call | REPL250919C00005000 | 21482 | 5.0 | 2.65 - 2.95 | 2.7 | In |
Call | REPL250919C00004500 | 27 | 4.5 | 3.0 - 3.5 | 2.75 | In |
Call | REPL250919C00004000 | 754 | 4.0 | 3.5 - 3.9 | 3.1 | In |
Call | REPL250919C00003500 | 111 | 3.5 | 4.0 - 4.4 | 3.9 | In |
Call | REPL250919C00003000 | 610 | 3.0 | 4.4 - 4.8 | 3.9 | In |
Call | REPL250919C00002500 | 311 | 2.5 | 4.7 - 5.2 | 5.1 | In |
Replimune Corporate Management
Colin Love | Chief Officer | Profile | |
Christopher Sarchi | Chief Officer | Profile | |
Carolyn Trott | Senior Assurance | Profile | |
Pamela Esposito | Chief Business Officer | Profile | |
Paul Bullock | Chief Head | Profile | |
Kari Jeschke | Senior Affairs | Profile |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Replimune Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Replimune. If investors know Replimune will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Replimune listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Replimune Group is measured differently than its book value, which is the value of Replimune that is recorded on the company's balance sheet. Investors also form their own opinion of Replimune's value that differs from its market value or its book value, called intrinsic value, which is Replimune's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Replimune's market value can be influenced by many factors that don't directly affect Replimune's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Replimune's value and its price as these two are different measures arrived at by different means. Investors typically determine if Replimune is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Replimune's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.